Sirio Pharma Co., Ltd., a global manufacturer of nutritional supplements, is launching BloomDays, a first-to-market gummy featuring Cargill’s EpiCor postbiotic ingredient.
 
BloomDays targets immune health and the growing gut health segment by combining Sirio’s expertise in developing and manufacturing health and wellness products with EpiCor, a whole food yeast fermentate evidenced by eight human and eight preclinical studies that demonstrate its effectiveness in supporting immune health by modulating the gut microbiome.
 
With 500 mg of EpiCor per two-gummy serving, the plant-based, sugar-free gummies contain only natural flavors and sweeteners.
 
“We are truly excited to collaborate with Cargill – a global leader committed to nourishing the world in a safe, responsible, and sustainable way to introduce an exceptional product that combines our strengths in health and wellness innovation,” said Sara Lesina, general manager, Europe and Americas, at Sirio. “BloomDays represents a milestone in our commitment to collaborating with reputable ingredients suppliers to launch innovative and unique solutions for our customers, helping them win in the market. BloomDays not only tastes great and provides meaningful health benefits but also offers a unique value proposition.”
 
The official launch of the product will take place at Expo West 2024 in Anaheim California from March 14th to March 16th. Attendees  are invited to try the new product at booth #3905, wehre Sirio will showcase the benefits and features of the gummies. The company plans to launch the product in Europe in the second half of 2024 at CPHI Milan.
 
“We are excited to collaborate with Sirio as they make the health benefits of EpiCor available to more people through the introduction of their new postbiotic gummy,” said Adam Hertell, global commercial director of dietary supplements at EpiCor. “With excellent stability properties, EpiCor offers the versatility and simplicity that pairs well with gummy manufacturing, making for a winning combination.”